Overview
- A ceremony with President Javier Milei and President Donald Trump will formally launch the pact.
- The legal text is not yet fully public and will be published in stages, with experts urging close attention to intellectual property rules that could pressure local pharmaceutical firms.
- The framework targets tariff reductions and the removal of bureaucratic obstacles, lowering costs for U.S.-sourced inputs and capital goods.
- Mining of lithium and copper plus beef and other agricultural exports are viewed as early winners, aligned with U.S. efforts to diversify critical supply chains away from China.
- Industries long shielded by high barriers face tougher import competition and likely restructuring, while the scale of new investment will depend on credible macro stability and predictable rules.